Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event prevention. - Massa G; Simeone N; Tinè G; Bracchi P; Miceli R; Pigni A; Lo Dico S; Zambelli L; Ricchini F; Bianchi GV; Caraceni A; Zecca E (Breast (Edinburgh, Scotland), 2025)